Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1323, 2010-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Evaluating EVR to PEG IFN-α-2b/ribavirin therapy worthwhile
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. :
REPEAT reaffirms the benefits of retreatment with PEG IFN-α-2a
Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. :
PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
PEG IFN- -2a improves QOL in hepatitis C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. :